Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.

Recently, the roles of SIRT1 and deleted in breast cancer 1 (DBC1) in human cancer have been extensively studied and it has been demonstrated that they are involved in many human carcinomas. However, their clinical significance for soft-tissue sarcomas has not been examined. In this study, we evalua...

Full description

Bibliographic Details
Main Authors: Jung Ryul Kim, Young Jae Moon, Keun Sang Kwon, Jun Sang Bae, Sajeev Wagle, Taek Kyun Yu, Kyoung Min Kim, Ho Sung Park, Ju-Hyung Lee, Woo Sung Moon, Ho Lee, Myoung Ja Chung, Kyu Yun Jang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3760851?pdf=render
_version_ 1828871194822049792
author Jung Ryul Kim
Young Jae Moon
Keun Sang Kwon
Jun Sang Bae
Sajeev Wagle
Taek Kyun Yu
Kyoung Min Kim
Ho Sung Park
Ju-Hyung Lee
Woo Sung Moon
Ho Lee
Myoung Ja Chung
Kyu Yun Jang
author_facet Jung Ryul Kim
Young Jae Moon
Keun Sang Kwon
Jun Sang Bae
Sajeev Wagle
Taek Kyun Yu
Kyoung Min Kim
Ho Sung Park
Ju-Hyung Lee
Woo Sung Moon
Ho Lee
Myoung Ja Chung
Kyu Yun Jang
author_sort Jung Ryul Kim
collection DOAJ
description Recently, the roles of SIRT1 and deleted in breast cancer 1 (DBC1) in human cancer have been extensively studied and it has been demonstrated that they are involved in many human carcinomas. However, their clinical significance for soft-tissue sarcomas has not been examined. In this study, we evaluated the expression and prognostic significance of the expression of SIRT1, DBC1, P53, β-catenin, cyclin D1, and KI67 in 104 cases of soft-tissue sarcomas.Immunohistochemical expression of SIRT1, DBC1, P53, β-catenin, and cyclin D1 were seen in 71%, 74%, 53%, 48%, and 73% of sarcomas, respectively. The expression of SIRT1, DBC1, P53, β-catenin, and cyclin D1 were significantly correlated with advanced clinicopathological parameters such as higher clinical stage, higher histological grade, increased mitotic counts, and distant metastasis. The expression of SIRT1, DBC1, P53, β-catenin, cyclin D1, and KI67 were significantly correlated with each other and positive expression of all of these predicted shorter overall survival and event-free survival by univariate analysis. Multivariate analysis revealed the expression of SIRT1 as an independent prognostic indicator for overall survival and event-free survival of sarcoma patients. In conclusion, this study demonstrates that SIRT1- and DBC1-related pathways may be involved in the progression of soft-tissue sarcomas and can be used as clinically significant prognostic indicators for sarcoma patients. Moreover, the SIRT1- and DBC1-related pathways could be new therapeutic targets for the treatment of sarcomas.
first_indexed 2024-12-13T06:27:46Z
format Article
id doaj.art-12fb0f9cb9ce4ac988d3ff6af6cb794d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T06:27:46Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-12fb0f9cb9ce4ac988d3ff6af6cb794d2022-12-21T23:56:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7473810.1371/journal.pone.0074738Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.Jung Ryul KimYoung Jae MoonKeun Sang KwonJun Sang BaeSajeev WagleTaek Kyun YuKyoung Min KimHo Sung ParkJu-Hyung LeeWoo Sung MoonHo LeeMyoung Ja ChungKyu Yun JangRecently, the roles of SIRT1 and deleted in breast cancer 1 (DBC1) in human cancer have been extensively studied and it has been demonstrated that they are involved in many human carcinomas. However, their clinical significance for soft-tissue sarcomas has not been examined. In this study, we evaluated the expression and prognostic significance of the expression of SIRT1, DBC1, P53, β-catenin, cyclin D1, and KI67 in 104 cases of soft-tissue sarcomas.Immunohistochemical expression of SIRT1, DBC1, P53, β-catenin, and cyclin D1 were seen in 71%, 74%, 53%, 48%, and 73% of sarcomas, respectively. The expression of SIRT1, DBC1, P53, β-catenin, and cyclin D1 were significantly correlated with advanced clinicopathological parameters such as higher clinical stage, higher histological grade, increased mitotic counts, and distant metastasis. The expression of SIRT1, DBC1, P53, β-catenin, cyclin D1, and KI67 were significantly correlated with each other and positive expression of all of these predicted shorter overall survival and event-free survival by univariate analysis. Multivariate analysis revealed the expression of SIRT1 as an independent prognostic indicator for overall survival and event-free survival of sarcoma patients. In conclusion, this study demonstrates that SIRT1- and DBC1-related pathways may be involved in the progression of soft-tissue sarcomas and can be used as clinically significant prognostic indicators for sarcoma patients. Moreover, the SIRT1- and DBC1-related pathways could be new therapeutic targets for the treatment of sarcomas.http://europepmc.org/articles/PMC3760851?pdf=render
spellingShingle Jung Ryul Kim
Young Jae Moon
Keun Sang Kwon
Jun Sang Bae
Sajeev Wagle
Taek Kyun Yu
Kyoung Min Kim
Ho Sung Park
Ju-Hyung Lee
Woo Sung Moon
Ho Lee
Myoung Ja Chung
Kyu Yun Jang
Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
PLoS ONE
title Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
title_full Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
title_fullStr Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
title_full_unstemmed Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
title_short Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.
title_sort expression of sirt1 and dbc1 is associated with poor prognosis of soft tissue sarcomas
url http://europepmc.org/articles/PMC3760851?pdf=render
work_keys_str_mv AT jungryulkim expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT youngjaemoon expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT keunsangkwon expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT junsangbae expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT sajeevwagle expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT taekkyunyu expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT kyoungminkim expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT hosungpark expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT juhyunglee expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT woosungmoon expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT holee expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT myoungjachung expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas
AT kyuyunjang expressionofsirt1anddbc1isassociatedwithpoorprognosisofsofttissuesarcomas